Detailed molecular signatures in three mouse models of Alzheimer’s disease at different disease stages allowed for identification of four approved medicines that may be potential Alzheimer’s treatments, a study revealed. The four medications that demonstrated efficiency are now used to treat hypertension (high blood pressure) and inflammation in humans. The study, “Identification and drug-induced reversion of molecular signatures of Alzheimer’s disease onset and progression in AppNL-G-F, AppNL-F, and 3xTg-AD mouse models,” was published in the…
You must be logged in to read/download the full post.
The post Mouse Study: 4 Approved Meds Are Potential Alzheimer’s Treatments appeared first on BioNewsFeeds.